ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
0.202
-0.010 (-4.55%)
At close: Jul 26, 2024, 4:00 PM
0.201
-0.001 (-0.25%)
After-hours: Jul 26, 2024, 7:22 PM EDT
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $5.92 million as of July 26, 2024. Its market cap has increased by 28.79% in one year.
Market Cap
5.92M
Enterprise Value
3.68M
1-Year Change
28.79%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since October 6, 2016, ReShape Lifesciences's market cap has decreased from $239.30M to $5.92M, a decrease of -97.52%. That is a compound annual growth rate of -37.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 4.90M | 48.48% |
| Dec 29, 2023 | 3.30M | - |
| Dec 30, 2022 | 3.30M | -88.70% |
| Dec 31, 2021 | 29.20M | 149.57% |
| Dec 31, 2020 | 11.70M | -19.86% |
| Dec 31, 2019 | 14.60M | -69.71% |
| Dec 31, 2018 | 48.20M | -58.20% |
| Dec 29, 2017 | 115.30M | -22.30% |
| Dec 30, 2016 | 148.40M | -37.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.47M |
| Xenetic Biosciences | 6.42M |
| NuCana | 6.40M |
| Virios Therapeutics | 6.40M |
| Notable Labs | 6.00M |
| Innovative Eyewear | 5.97M |
| GT Biopharma | 5.92M |
| Oragenics | 5.92M |